December 8, 2010 — Compared with low doses, moderate doses of inhaled corticosteroids (ICSs) may not give an added benefit to children with mild to moderate persistent asthma, according to the results ...

(CNN) — The U.S. Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people with multiple food allergies.

Please provide your email address to receive an email when new articles are posted on . Rademikibart improved lung function and asthma control in adults with moderate to severe persistent asthma. The ...

Asthma flares can strike when allergens are high or after an illness, and many people with the condition want to know how they can manage symptoms and when to adjust medications. A News 9 viewer says ...

Providers from an asthma primary care program found telemedicine to be effective in both caring for children with asthma and addressing unmet social needs that may exacerbate their asthma outcomes.

(MENAFN- Market Press Release) December 13, 2025 7:27 am - The Dupixent market for moderate-to-severe asthma is valued at $3.25 billion in 2025 and is projected to grow at a 14% CAGR through 2032.

There's been *** rise in childhood food allergies in recent years affecting Children nationwide. These 12 Long Island investigative reporter Rachel Yank Kunis is here now to break down the numbers for ...

(CNN) — The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.